Evidence map›Paper›PMID 35258090›Full record

ArticleALTEX2022

Application of evidence-based methods to construct mechanism-driven chemical assessment frameworks.

Sebastian Hoffmann, Elisa Aiassa, Michelle Angrish, Claire Beausoleil, Frederic Y Bois, Laura Ciccolallo, Peter S Craig, Rob B M De Vries, Jean Lou C M Dorne, Ingrid L Druwe and 29 more

Open access · goldAbstract readEditorial
In one paragraph

Article in ALTEX, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. A workflow for human health hazard evaluation using transcriptomic data and Key Characteristics-based gene sets.Toxicological sciences : an official journal of the Society of Toxicology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Lung Organoids for Hazard Assessment of Nanomaterials.International journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

39 authors at 1 institution in 1 country.

Sebastian HoffmannEvidence-based Toxicology Collaboration (EBTC) at Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Elisa AiassaEuropean Food Safety Authority (EFSA), Parma, Italy.
Michelle AngrishUnited States Environmental Protection Agency, Office of Research and Development, Center for Public Health and Environmental Assessment, Research Triangle Park, NC, USA.
Claire BeausoleilANSES, Risk Assessment Department, Maisons-Alfort, France.
Frederic Y BoisCertara UK, Simcyp Division, Sheffield, UK.
Laura CiccolalloEuropean Food Safety Authority (EFSA), Parma, Italy.
Peter S CraigDurham University, Durham, UK.
Rob B M De VriesEvidence-based Toxicology Collaboration (EBTC) at Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Jean Lou C M DorneEuropean Food Safety Authority (EFSA), Parma, Italy.
Ingrid L DruweUnited States Environmental Protection Agency, Office of Research and Development, Center for Public Health and Environmental Assessment, Research Triangle Park, NC, USA.
Stephen W EdwardsRTI International, Research Triangle Park, NC, USA.
Chantra EskesSeCAM, Magliaso, Switzerland.
Marios GeorgiadisEuropean Food Safety Authority (EFSA), Parma, Italy.
Thomas HartungEvidence-based Toxicology Collaboration (EBTC) at Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Aude KienzlerEuropean Commission, Joint Research Centre, Ispra, Italy.
Elisabeth A KristjanssonUniversity of Ottawa, Ottawa, Canada.
Juleen LamCalifornia State University, East Bay, CA, USA.
Laura MartinoEuropean Food Safety Authority (EFSA), Parma, Italy.
Bette MeekUniversity of Ottawa, Ottawa, Canada.
Rebecca L MorganDepartment of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.
Irene Munoz-GuajardoEuropean Food Safety Authority (EFSA), Parma, Italy.
Pamela D NoyesUnited States Environmental Protection Agency, Office of Research and Development, Center for Public Health and Environmental Assessment, Research Triangle Park, NC, USA.
Elena ParmelliEuropean Commission, Joint Research Centre, Ispra, Italy.
Aldert PiersmaCentre for Health Protection (RIVM), Bilthoven, the Netherlands.
Andrew RooneyDivision of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA.
Emily SenaUniversity of Edinburgh, Edinburgh, UK.
Kristie SullivanPhysicians Committee for Responsible Medicine, Washington, DC, USA.
José TarazonaEuropean Food Safety Authority (EFSA), Parma, Italy.
Andrea TerronEuropean Food Safety Authority (EFSA), Parma, Italy.
Kris ThayerUnited States Environmental Protection Agency, Office of Research and Development, Center for Public Health and Environmental Assessment, Research Triangle Park, NC, USA.
Jan TurnerSafer Medicines Trust, Kingsbridge, UK.
Jos VerbeekUniversity of Eastern Finland, Kuopio, Finland
Didier VerlooEuropean Food Safety Authority (EFSA), Parma, Italy.
Mathieu VinkenVrije Universiteit Brussel, Brussels, Belgium.
Sean WatfordBooz Allen Hamilton, Rockville, MD, USA.
Paul WhaleyEvidence-based Toxicology Collaboration (EBTC) at Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Daniele WikoffToxStrategies, Asheville, NC, USA.
Kate WillettHumane Society International, Washington, DC, USA.
Katya TsaiounEvidence-based Toxicology Collaboration (EBTC) at Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Johns Hopkins University · US

Funding

Scientific Cyberinfrastructure Research ProgramZIAES103385 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI WALKER, VICKIE · 2022 to 2025
$17.4M
Intramural EPA EPA999999
6 · The paper itself

Abstract

The workshop titled “Application of evidence-based methods to construct mechanism-driven chemical assessment frameworks” was co-organized by the Evidence-based Toxicology Collaboration and the European Food Safety Authority (EFSA) and hosted by EFSA at its headquarters in Parma, Italy on October 2 and 3, 2019. The goal was to explore integration of systematic review with mechanistic evidence evaluation. Participants were invited to work on concrete products to advance the exploration of how evidence-based approaches can support the development and application of adverse outcome pathways (AOP) in chemical risk assessment. The workshop discussions were centered around three related themes: 1) assessing certainty in AOPs, 2) literature-based AOP development, and 3) integrating certainty in AOPs and non-animal evidence into decision frameworks. Several challenges, mostly related to methodology, were identified and largely determined the workshop recommendations. The workshop recommendations included the comparison and potential alignment of processes used to develop AOP and systematic review methodology, including the translation of vocabulary of evidence-based methods to AOP and vice versa, the development and improvement of evidence mapping and text mining methods and tools, as well as a call for a fundamental change in chemical risk and uncertainty assessment methodology if to be conducted based on AOPs and new approach methodologies (NAM). The usefulness of evidence-based approaches for mechanism-based chemical risk assessments was stressed, particularly the potential contribution of the rigor and transparency inherent to such approaches in building stakeholders’ trust for implementation of NAM evidence and AOPs into chemical risk assessment.

Indexed as

Adverse Outcome PathwaysFood SafetyHumansItalyRisk Assessmentadverse outcome pathwaycertainty assessmentevidence-based toxicologynew approach methodologiessystematic evidence synthesis

Identifiers

PMID35258090
PMCPMC9466297
OpenAlexW4220880022

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.